# Tafluprost

## Taflotan-S 0.0015%，0.3mL ophthalmic solution

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | ETAFS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 適應症     | Reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 用法用量   | Instill 1 drop in the affected eye(s) once daily in the evening.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 禁忌       | Hypersensitivity to Tafluprost.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 副作用     | >10%: Ocular: Conjunctival hyperemia (4% to 20%) 1% to 10%: Central nervous system: Headache (6%) Genitourinary: Urinary tract infection (2%) Ocular: Stinging/irritation (7%), conjunctivitis (5%), cataract (3%), dry eye (3%), ocular pain (3%), eyelash darkening (2%), eyelash growth (2%), vision blurred (2%) Respiratory: Common cold (4%), cough (3%) Postmarketing and/or case reports (Limited to important or life-threatening): Dyspnea, exacerbation of asthma; macular edema (reported with prostaglandin analog use) |
| 孕期建議   | No (limited) human data – probably compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

